
News|Slideshows|March 31, 2022
American College of Cardiology 71st Scientific Sessions: Science Preview, April 2, 2022
Author(s)Patient Care Editorial Staff
ACC 2022. ACC late-breaking clinical trial sessions begin Sat, April 2, 2022. Our short slide shows highlight the studies of interest to primary care clinicians.
Advertisement
At the American College of Cardiology's 71st Scientific Session in Washington, DC, April 2-4, the latest findings spanning the breadth of cardiovascular disease research will be presented in late-breaking science sessions on all 3 days.
Whether you are attending in person or remotely, use these quick slide-show guides to review sessions and study titles. Use the "late-breaking" link to visit the ACC program page where all study abstracts will be available as the findings are presented. Start below with the hot topics on Day 1, including research on mavacamten, sotagliflozin , and bentracimab.
Sunday, April 3, 2022 Late Breaking Clincial Trials
Monday, April 4, 2022 Late Breaking Clinical Trials
More News from ACC on Patient Care
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials
2
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
3
Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
4
Primary Care Training Improves Uptake and Long-Term Use of Long-Acting Reversible Contraception
5